Abbott has announced the completion of enrolment in the TECTONIC CAD IVL investigational device exemption (IDE) study, a pivotal trial evaluating the safety and effectiveness of the company’s SonicForce coronary intravascular lithotripsy (IVL) system in patients with severely calcified, de novo coronary lesions prior to stent placement. The TECTONIC CAD IVL trial enrolled 335 patients […] The post Pivotal trial of Abbott’s coronary IVL system completes enrolment appeared first on Cardiovascular News .